Comparison of two chemotherapeutic regimens − mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) − in advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

Comparison of two chemotherapeutic regimens − mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) − in advanced non-small-cell lung cancer

Published:1994-04 Issue:4 Volume:5 Page:323-327
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Barón M.González,Feliu J.,Espinosa E.,Girón C.García,Blanco E.,Garrido P.,Colmenarejo A.,Ordóñez A.,Moyano A.,de la Gándara I.,Zamora P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/5/4/323/508311/5-4-323.pdf

Reference31 articles.

1. Chemotherapy of non-small-cell lung cancer. A reappraisal and look to the future;Bakowski;Cancer Treat Rev,1983

2. An analysis of 134 phase II trials in non-small-cell lung cancer. Proc IV World Conf on Lung Cancer;Kris;Toronto,1985

3. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer;Depierre;Am J Clin Oncol,1991

4. A phase II study of taxol in patients with non-small-cell lung cancer;Murphy;Proc Am Soc Clin Oncol,1992

5. Trial of the combination of mitomycin, vindesine and cisplatin in patients with advanced non-small-cell lung cancer;Kris;Cancer Treat Rep,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncopaz cooperative group;Clinical and Translational Oncology;2006-03

2. Chemotherapy for Advanced Disease Non-Small Cell Lung Cancer;Malignant Tumors of the Lung;2004

3. Mitomycin C: a clinical update;Cancer Treatment Reviews;2001-02

4. Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.;Journal of Clinical Oncology;1998-05

5. A survey of the ethical considerations in randomised trials for lung cancer;Lung Cancer;1998-03